RenovoRx (RNXT) executive discloses direct ownership of 25,000 shares

Rhea-AI Filing Summary

RenovoRx, Inc. filed an initial ownership report for company executive Mark Voll. The filing shows he directly holds 25,000 shares of RenovoRx common stock. A footnote explains these securities were purchased in open-market transactions before his appointment to a senior executive role at the company.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

VOLL MARK

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	25,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The securities were purchased in the open market prior to the Reporting Person's appointment as Chief Executive Officer of the Issuer.

	/s/ Mark Voll	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Mark Voll's Form 3 filing for RNXT report?

The Form 3 for RenovoRx (RNXT) reports that executive Mark Voll directly holds 25,000 shares of common stock. This is an initial ownership statement, not a new trade, establishing his existing equity position as an insider.

How many RenovoRx (RNXT) shares does Mark Voll beneficially own?

Mark Voll is reported to beneficially own 25,000 shares of RenovoRx common stock directly. This holding is disclosed in his initial insider report and reflects stock he already owned before assuming his current executive role.

Were the RNXT shares in Mark Voll's Form 3 recently bought or already held?

According to a footnote, the 25,000 RenovoRx shares were purchased in the open market before Mark Voll’s appointment as a senior executive. The Form 3 therefore records an existing position rather than a new purchase or sale.

Does Mark Voll’s Form 3 for RenovoRx indicate any insider buying or selling?

The Form 3 does not show a new insider trade. It classifies the entry as a holding, simply reporting that Mark Voll directly owns 25,000 common shares, which were acquired earlier in open-market purchases.

Is Mark Voll’s ownership in RNXT direct or through another entity?

The filing states that Mark Voll’s 25,000 RenovoRx shares are held with direct ownership. There is no indication in the data provided that these shares are held through a trust, partnership, or other indirect entity.